SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Hughes, G. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hughes, G. R.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Autoimmune Diseases
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Reviews

Review : Hughes' syndrome: The antiphospholipid syndrome

A historical view

Graham RV Hughes

Lupus Research Unit, The Rayne Institute, St Thomas' Hospital, London, UK

In the 15 years since our description of the antiphospholipid syndrome, it has become recognised as an important disease, not only in the world of lupus but in the broader areas of obstetrics, neurology and vascular disease.

Although advances have been made in the understanding of the interactions of antibodies, protein co-factors, clotting molecules, endothelium and platelets, much still needs to be learnt about management where strokes, in particular, continue to cause significant morbidity.

Key Words: antiphospholipid syndrome • Hughes' syndrome • co-factor • thrombosis

Lupus, Vol. 7, No. 2 suppl, S1-S4 (1998)
DOI: 10.1177/096120339800700201


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
LupusHome page
J. Carvalho, C. Freitas, I. Lima, C. Leite, and L. Lage
Primary antiphospholipid syndrome with thrombotic thrombocytopenic purpura: a very unusual association
Lupus, August 1, 2009; 18(9): 841 - 844.
[Abstract] [PDF]


Home page
Qual Saf Health CareHome page
P Hudelson, A Cleopas, V Kolly, P Chopard, and T Perneger
What is quality and how is it achieved? Practitioners' views versus quality models
Qual. Saf. Health Care, February 1, 2008; 17(1): 31 - 36.
[Abstract] [Full Text] [PDF]


Home page
Qual Saf Health CareHome page
S M Handler, N G Castle, S A Studenski, S Perera, D B Fridsma, D A Nace, and J T Hanlon
Patient safety culture assessment in the nursing home
Qual. Saf. Health Care, December 1, 2006; 15(6): 400 - 404.
[Abstract] [Full Text] [PDF]


Home page
Ann Fam MedHome page
M. C. Hroscikoski, L. I. Solberg, J. M. Sperl-Hillen, P. G. Harper, M. P. McGrail, and B. F. Crabtree
Challenges of Change: A Qualitative Study of Chronic Care Model Implementation
Ann. Fam. Med, July 1, 2006; 4(4): 317 - 326.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
T P Greco, M D Amos, A M Conti-Kelly, J D Naranjo, and J W Ijdo
Testing for the antiphospholipid syndrome: importance of IgA anti-beta 2-glycoprotein I
Lupus, January 1, 2000; 9(1): 33 - 41.
[Abstract] [PDF]



Advertisement